Avidity Biosciences Stock Target Price and Analyst Consensus

RNA Stock  USD 31.11  1.02  3.17%   
The current analyst and expert consensus on Avidity Biosciences is Strong Buy, with 7 strong buy opinions. The current projected Avidity Biosciences target price consensus is 68.27 with 11 analyst opinions. Check out Macroaxis Advice on Avidity Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.
The most common way Avidity Biosciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Avidity Biosciences executives and customers to further validate their buy or sell advice. Avidity Biosciences buy-or-sell recommendation module provides average expert sentiment on the projected Avidity Biosciences target price to derive its highest and lowest estimates based on projected price volatility of 3.3195.
Lowest Forecast
62.13
Highest Forecast
75.78
Target Price
68.27
At present, Avidity Biosciences' Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit Margin is expected to grow to 0.74, whereas Pretax Profit Margin is forecasted to decline to (31.06). At present, Avidity Biosciences' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 68 M, whereas Other Liabilities is forecasted to decline to about 1.1 M.
  
It's important to approach Avidity Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Avidity Biosciences Target Price Consensus

Avidity target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Avidity Biosciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   11  Strong Buy
Most Avidity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Avidity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Avidity Biosciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Avidity Biosciences Target Price Projection

Avidity Biosciences' current and average target prices are 31.11 and 68.27, respectively. The current price of Avidity Biosciences is the price at which Avidity Biosciences is currently trading. On the other hand, Avidity Biosciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Avidity Biosciences Market Quote on 15th of March 2025

Low Price30.9Odds
High Price33.16Odds

31.11

Target Price

Analyst Consensus On Avidity Biosciences Target Price

Low Estimate62.13Odds
High Estimate75.78Odds

68.2727

Historical Lowest Forecast  62.13 Target Price  68.27 Highest Forecast  75.78
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Avidity Biosciences and the information provided on this page.

Avidity Biosciences Analyst Ratings

Avidity Biosciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Avidity Biosciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Avidity Biosciences' financials, market performance, and future outlook by experienced professionals. Avidity Biosciences' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Avidity Biosciences price targets

Avidity Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Avidity Biosciences' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Avidity Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Avidity Biosciences' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Avidity Biosciences Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Avidity Biosciences is a key component of Avidity Biosciences valuation and have some predictive power on the future returns of a Avidity Biosciences.
Hype
Prediction
LowEstimatedHigh
27.7631.0834.40
Details
Intrinsic
Valuation
LowRealHigh
28.0040.4043.72
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.07-0.88-0.55
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
ESG Investing Idea
ESG Investing
Invested few shares
Momentum Idea
Momentum
Invested few shares
Business Services Idea
Business Services
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 60 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested few shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 40 shares
Apparel Idea
Apparel
Invested over 40 shares
Casinos Idea
Casinos
Sold over 90 shares
Basic Utilities Idea
Basic Utilities
Invested over 90 shares
When determining whether Avidity Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avidity Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avidity Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avidity Biosciences Stock:
Check out Macroaxis Advice on Avidity Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Please note, the presentation of Avidity Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Avidity Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Avidity Biosciences' management manipulating its earnings.